Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke

General Hospital Psychiatry

Volumn 31, Issue 1, 2009, Pages 30-32

  Himelhoch, Seth ^a   Leith, Jaclyn ^a   Goldberg, Richard ^a   Kreyenbuhl, Julie ^a   Medoff, Deborah ^a   Dixon, Lisa ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular risk factors; Care; Management; Schizophrenia; Smokers; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COMPARATIVE STUDY; COUNSELING; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCHIZOPHRENIA; SMOKING CESSATION;

ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICES; RISK FACTORS; RISK REDUCTION BEHAVIOR; SCHIZOPHRENIA; SMOKING; UNITED STATES;

EID: 58149114685     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2008.07.007     Document Type: Article

References (14)

1. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 24 8 (2004) e149-e161
2. Hippisley-Cox J., Parker C., Coupland C., and Vinogradova Y. Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study. Heart 93 10 (2007) 1256-1262
3. Kreyenbuhl J., Dickerson F.B., Medoff D.R., Brown C.H., Goldberg R.W., Fang L., et al. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis 194 6 (2006) 404-410
4. Goldberg R.W., Kreyenbuhl J.A., Medoff D.R., Dickerson F.B., Wohlheiter K., Fang L.J., et al. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv 58 4 (2007) 536-543
5. Frayne S.M., Halanych J.H., Miller D.R., Wang F., Lin H., Pogach L., et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med 165 22 (2005) 2631-2638
6. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 19 (2001) 2486-2497
7. de Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76 2-3 (2005) 135-157
8. Himelhoch S., and Daumit G. To whom do psychiatrists offer smoking cessation counseling?. Am J Psychiatry 160 12 (2003) 2228-2230
9. Dixon L.B., Kreyenbuhl J.A., Dickerson F.B., Donner T.W., Brown C.H., Wohlheiter K., et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatr Serv 55 8 (2004) 892-900
10. Weissman E.M., Zhu C.W., Schooler N.R., Goetz R.R., and Essock S.M. Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics. J Clin Psychiatry 67 9 (2006) 1323-1326
11. Shuter J., and Bernstein S.L. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res 10 4 (2008) 731-736
12. Newman S.C., and Bland R.C. Mortality in a cohort of patients with schizophrenia: a record linkage study. Canadian Journal of Psychiatry 36 (1991) 239-245
13. Osby U., Correia N., Brandt L., Ekbom A., and Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 45 1-2 (2000) 21-28
14. Brown S., Inskip H., and Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 177 (2000) 212-217